Roxas, Antonio, JR.. D.
HRN: 25-17-77 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/03/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/03/2024
06/09/2024
IVT
500mg
Q8H
UGIB Prob Sec To BPUD Sec To Hpylori Infection
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes